Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for API intermediates without heavy metals.
Patent CN114213254B details a novel photoredox method for beta-nitroketones. Enables cost reduction in pharmaceutical intermediate manufacturing with high yields.
Patent CN111100085A reveals a green deep eutectic solvent method for synthesizing benzoxazine derivatives, offering cost reduction in API manufacturing and scalable production.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering safer CO-surrogate protocols and enhanced supply chain reliability for API intermediates.
Patent CN114160206B reveals a novel chiral copper catalyst enabling high-yield, enantioselective synthesis of indole pharmaceutical intermediates with superior purity.
Patent CN113105402B reveals a metal-free iodine-promoted route for high-purity triazole synthesis, offering significant cost reduction and scalable manufacturing for global API supply chains.
Patent CN109096139B discloses a novel metal-free method for preparing alpha-carbonyl amides using water as an oxygen source, offering significant cost and purity advantages for pharmaceutical intermediate manufacturing.
Novel axial chiral bisindole catalysts for asymmetric synthesis. Superior stereoselectivity and mild conditions for pharmaceutical intermediates manufacturing.
Recent patent literature demonstrates a Ni(II)-catalyzed one-step synthesis of 3-ether isoindolinone intermediates with 88-98% yield, enabling cost reduction in API manufacturing and supply chain stability.
Solve high-cost deuteration challenges with 98% deuterated aldehyde yield. Our CDMO expertise in metal-free catalysis ensures scalable, pure intermediates for drug development.
Solve toxic reagent risks in phenanthridinone production. Discover 1 atm CO pressure process for high-yield, scalable API intermediates with reduced supply chain risks.
Solve supply chain risks in chiral synthesis with this novel protonic acid catalyst. Achieve 98% ee and 96% yield in ruthenium-catalyzed reactions. Contact us for custom synthesis.
Discover a cost-effective, high-yield synthesis of tolvaptan intermediate with no special equipment or toxic reagents. Reduce production risks and costs for your API manufacturing.
Solve quinoline-4(1H)-one synthesis challenges with this one-step palladium-catalyzed method. Reduce costs, improve yield, and ensure supply chain stability for your API production.
Discover how palladium-catalyzed carbonylation enables cost-effective, high-yield synthesis of 2-trifluoromethyl quinazolinone for drug development. Reduce supply chain risks and improve scalability.
Solve 2-trifluoromethyl quinazolinone synthesis challenges with cost-effective, scalable palladium-catalyzed method. Reduce R&D costs and supply chain risks for pharma intermediates.
Solve quinazolinone synthesis challenges with palladium-catalyzed carbonylation. Achieve 83% yield, broad substrate tolerance, and 77% total yield for Rutaecarpine. Scale to 100 MT/annual.
Discover a metal-free, air-stable C2-phosphono indole synthesis method with >99% purity, high atom economy, and scalable production for pharmaceutical applications.
Solve biotin synthesis cost challenges with copper-catalyzed hydroxybiotin production. 99% yield, no special palladium catalysts. Contact for CDMO solutions.
Solve azacyclooctanofuranone synthesis challenges with iron-catalyzed one-pot method. Reduce costs, improve yield, and ensure green production for pharma R&D and procurement teams.